At Silence, we aim to transform peoples’ lives around the world by silencing diseases through our precision-engineered medicines and driving positive change for the communities around us. One area we’re working on developing a potential gene silencing therapy for is Polycythemia Vera (PV). Look out for further information about our study launched at the start of 2023 in the US (and beyond).